BMS-906024

BMS-906024
Identifiers
PubChem CID
PubChem SID
ChemSpider
Chemical and physical data
Formula C26H26F6N4O3
Molar mass 556.500 g/mol
3D model (JSmol)

New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast, lung, and colon cancers and leukemia.[1] The drug works as an pan-Notch inhibitor. The structure is one of a set patented in 2012,[2] and it currently being studied in clinical trials.[3][4]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.